Discover how AAV-based gene therapy delivers anti-eosinophil antibodies, offering hope for chronic hypereosinophilia ...
and other AAV serotypes to identify novel capsids optimized for AAV delivery for specific therapeutic applications. Voyager’s next-generation capsids are designed to deliver innovative AAV-based ...
A study published in Human Gene Therapy has involved the generation of a human monoclonal antibody (mAb) directed against ...
New research by Oregon Health & Science University scientists has uncovered multiple factors to improve gene delivery to the ...
Professor of Chemical and Biomolecular Engineering, Department of Bioengineering, Director of the Berkeley Stem Cell Center, University of California at Berkeley There have been an increasing number ...
Analogous to drug repurposing, AAV capsids can be used for gene delivery applications other than originally intended. With that in mind, we tested two of the capsids, AAV-F and AAV-S, from our ...
Adeno-associated virus (AAV) vectors are at the forefront of gene therapy, revolutionizing treatments for genetic disorders. With their increasing adoption, precise tools are vital for quantifying AAV ...